Olfactory Deficits Predict Cognitive Improvement on Donepezil in Patients With Depression and Cognitive Impairment: A Randomized Controlled Pilot Study

Alzheimer Dis Assoc Disord. 2016 Jan-Mar;30(1):67-9. doi: 10.1097/WAD.0000000000000107.
No abstract available

Publication types

  • Randomized Controlled Trial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Cholinesterase Inhibitors / therapeutic use*
  • Cognition / physiology*
  • Cognition Disorders / complications
  • Cognition Disorders / drug therapy*
  • Depression / complications*
  • Donepezil
  • Female
  • Humans
  • Indans / therapeutic use*
  • Male
  • Middle Aged
  • Neuropsychological Tests
  • Olfaction Disorders / drug therapy*
  • Pilot Projects
  • Piperidines / therapeutic use*

Substances

  • Cholinesterase Inhibitors
  • Indans
  • Piperidines
  • Donepezil